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Abstract
Objectives: To determine if caloric restriction (CR) would cause changes in plasma metabolic intermediates in response to a
mixed meal, suggestive of changes in the capacity to adapt fuel oxidation to fuel availability or metabolic flexibility, and to
determine how any such changes relate to insulin sensitivity (SI).
Methods: Forty-six volunteers were randomized to a weight maintenance diet (Control), 25% CR, or 12.5% CR plus 12.5%
energy deficit from structured aerobic exercise (CR+EX), or a liquid calorie diet (890 kcal/d until 15% reduction in body
weight)for six months. Fasting and postprandial plasma samples were obtained at baseline, three, and six months. A
targeted mass spectrometry-based platform was used to measure concentrations of individual free fatty acids (FFA), amino
acids (AA), and acylcarnitines (AC). SI was measured with an intravenous glucose tolerance test.
Results: Over three and six months, there were significantly larger differences in fasting-to-postprandial (FPP)
concentrations of medium and long chain AC (byproducts of FA oxidation) in the CR relative to Control and a tendency
for the same in CR+EX (CR-3 month P=0.02; CR-6 month P=0.002; CR+EX-3 month P=0.09; CR+EX-6 month P=0.08). After
three months of CR, there was a trend towards a larger difference in FPP FFA concentrations (P=0.07; CR-3 month P=0.08).
Time-varying differences in FPP concentrations of AC and AA were independently related to time-varying SI (P,0.05 for
both).
Conclusions: Based on changes in intermediates of FA oxidation following a food challenge, CR imparted improvements in
metabolic flexibility that correlated with improvements in SI.
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Introduction
Caloric restriction provides metabolic benefits in a variety of
nonhuman animal species (reviewed in [1]). There is great interest
in determining whether these metabolic benefits translate to
humans and whether caloric restriction induces favorable changes
in metabolic indicators of enhanced longevity. The NIH-
sponsored Comprehensive Assessment of the Long Term Effects
of Reducing Intake of Energy (CALERIE) was a Phase I pilot
study that examined the potential health benefits of caloric
restriction in sedentary, non-obese, healthy individuals. While the
primary aim of the original study was to determine the impact of
caloric restriction on biomarkers of longevity and metabolic
adaptation, the secondary aims of CALERIE were to evaluate the
impact of caloric restriction on risk factors for type 2 diabetes
mellitus and cardiovascular disease. In this analysis of data from
the Pennington-site CALERIE, we sought to understand if caloric
restriction could improve metabolic flexibility.
Metabolic flexibility is an emerging indicator of (metabolic)
health [2,3]. In its most general sense, metabolic flexibility refers to
the efficient variation of energy substrate utilization depending on
substrate availability and energy demand, or the capacity to adapt
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2fuel oxidationto fuel availability [3],and this is how we interpretthe
term in this report. To preserve available glucose for use by the
brain in the fasting state, most body organs oxidize free fatty acids
and amino acids, released through lipolysis and proteolysis,
respectively. After a balanced mixed meal, glucose is oxidized in
the brain and other organs while lipolysis in adipose tissue and
glycogenolysis in the liver are inhibited by increases in insulin levels
inducedbytheingestedcalories.Excessglucoseis storedasglycogen
in the liver and skeletal muscle, and ingested lipids are stored as fat,
preferentially in adipose tissue. Efficient substrate switching after a
mixed meal manifests as a decrease in fatty acid oxidation and a fall
in circulating free fatty acids and intermediates of fatty acid
oxidation [2,3]. Impairment in this normal mode of substrate
switching is associated with obesity, skeletal muscle insulin
resistance, metabolicsyndrome, andtype2 diabetes mellitus[3,4,5].
Prior studies have examined the effects of type 2 diabetes, obesity,
insulin resistance, and a family history of type 2 diabetes on
metabolic flexibility, defined as the ability to shift substrate oxidation
and measured by whole body and skeletal muscle respiratory
quotient (RQ) [3]. Such investigations have evaluated RQ changes
in response to a hyperinsulinemic clamp, high carbohydrate or high
fat meals, and high carbohydrate or high fat diets [3].
Thus far in human studies, metabolic flexibility has been
measured as alterations in RQ, which serves as a surrogate for
substrate oxidation and ranges from 1 for total carbohydrate
oxidation to 0.7 for total fat oxidation
3. Using changes in RQ as
the primary variable, weight loss (with and without exercise
training) has been associated with a trend towards increased
metabolic flexibility, measured in the fasting state alone or in
response to a hyperinsulinemic clamp [6,7,8]. However, in the
setting of an intervention where a mixed meal is delivered, we don
not expect RQ to change enough to detect in a heterogenous
population. In the current study, we propose that measurement of
a broad panel of metabolites that serve as substrates and products
of key metabolic pathways can potentially provide a more
comprehensive snapshot of changes in metabolic fuel selection in
the fasted/fed transition. This concept has been demonstrated in
animal studies [9], but not in humans. Derived primarily from
intermediate steps in fatty acid oxidation, a rise in plasma levels of
even chain acylcarnitines could reflect increased substrate
availability for beta oxidation (complete or incomplete) and/or
imposition of a shift in flux limitations. Elevated circulating fatty
acids might reflect a block in beta oxidation and/or increased
lipolysis. Similarly, amino acid concentration increases might
reflect a decrease in amino acid use for protein synthesis or as an
energy substrate, or an increase in protein turnover.
The main objective of the current study was to determine the
effect of caloric restriction on the shift in substrate utilization in
response to a mixed meal. A secondary aim was to evaluate the
relationship of changes in metabolic flexibility, as measured by
metabolic intermediate concentration changes from the fasted to
fed states, to changes in insulin sensitivity over the course of a six-
month intervention period. We hypothesized that caloric restric-
tion, or the combination of caloric restriction and exercise, would
cause a larger difference in the fasting to postprandial concentra-
tions of fatty acids and acylcarnitines over the intervention period
when compared to non-caloric restricted controls.
Methods
Design and Participants
Forty-six healthy, non-smoking, overweight (25#BMI,30), 25–
50 year old men and 25–45 year old women were recruited to
participate in and completed a six-month intervention (clinical trials
number NCT00427193). The protocol for this trial and supporting
CONSORT checklist are available as supporting information; see
ChecklistS1and ProtocolS1.Participantswereexcludediftheyhad
a history of cardiovascular disease, elevated blood pressure (.140/
90 mmHg), high fasting blood glucose (.126 mg/dL), chronic
medications (except oral contraceptives), smoking, regular exercise
(more than twice a week), abnormal thyroid function or abnormal
ECG. Participant flow in the trial is shown in Figure 1.
Ethics Statement
The study was approved by the Pennington Biomedical
Research Center (PBRC, Baton Rouge, LA) Institutional Review
Board and the CALERIE Data Safety Monitoring Board, and
written informed consent was obtained for all participants.
Interventions
Participants were randomized into one of four groups for 24
weeks: healthy weight maintenance diet (Control); caloric
restriction (CR): 25% caloric restriction from baseline energy
requirements; caloric restriction and exercise (CR+EX): 12.5%
caloric restriction and 12.5% increase in energy expenditure
through structured aerobic exercise; or, liquid calorie diet (LCD;
890 kcal/day) to rapidly achieve 15% weight loss followed by
weight stabilization with a eucaloric diet designed to maintain
body mass at this level. The group assignment was stratified to
ensure equal distributions of sex and BMI in the four groups, and
participants were analyzed as intention-to-treat.
Diets
As previously described, total energy expenditure measured
using doubly labeled water was used for calculation of energy
requirements [10]. All diets were based on American Heart
Association (AHA) recommendations (30% calories from fat, 15%
from protein and 55% from carbohydrate).
Structured Exercise
Individual exercise prescriptions were based on increasing
energy expenditure 12.5% above resting energy expenditure as
previously described [10]. Exercise modes included walking,
running, and cycling at a frequency of five days per week, with
at least three supervised sessions per week. Adherence was assessed
with heart rate monitors (Polar S-610).
Metabolic Profiling
Plasma samples were obtained after an overnight fast and 60
and 90 minutes after a standard lunch mixed meal (postprandial
and pooled) on an inpatient research unit at each of three time
points: baseline (before initiation of the intervention), three months
following initiation of the intervention and six months following
initiation of the intervention (study exit). Samples were prepared
and stored at 280uC for later analysis.
Targeted mass spectrometry was used to measure concentra-
tions of eight free fatty acids (FFA), 15 amino acids (AA), and 45
acylcarnitines (AC) as described previously [11]. In brief, after
methylation with iodomethane and partial purification, FFA
concentrations were measured with gas chromatography/mass
spectrometry (GC/MS). After methanol precipitation and ester-
ification, AC and AA concentrations were measured with tandem
mass spectrometry (MS/MS).
Insulin sensitivity (SI)
As previously reported [12], a frequently sampled intravenous
glucose tolerance test (IVGTT) was performed with 300 mg/kg of
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injected at minute 20. Concentrations of insulin (DPC 2000,
Diagnostic Product Corporation, Los Angeles, CA) and glucose
(Synchron CX7, Beckman-Coulter, Brea, CA) were measured at
each sampling time. Using these concentrations, SI was derived
using Bergman’s Minimal Model [13,14].
Data Analysis
Principal components analysis (PCA) was used as a data
reduction technique. PCA is commonly used to reduce a large
number of observed variables to a smaller number of constructed
variables (principal components) that account for the variance in
the observed variables [15]. It has been used for data reduction in
prior studies of metabolic intermediates [11,16,17,18].
Specifically, we created a fasting-to-postprandial change score
for each metabolite at each time point as follows: Change
score=postprandial – fasting concentration. Then, PCA was
performed using varimax rotation on the baseline change score for
each metabolite class such that one PCA change score analysis was
performed for each domain of FFAs, ACs, and AAs. The number
of components retained for each model was selected to balance
parsimony and the total percent of variance explained. Then,
component loadings from baseline change PCAs were applied to
the fasting to postprandial change scores for the three- and six-
month time points normalized to the baseline values, and
component scores were generated for each metabolic domain at
each time point. This normalization provided a common metric
for estimating change in components over time.
To determine whether the intervention affected change in
fasting-to-postprandial differences (FPPD) over time, we used
mixed models [16] to regress FPPD on time, intervention group
and an intervention group-by-time product term. FPPD were
based on the principal components described above. For these
models, the intervention group-by-time product term indicated
whether changes over time in FPPD vary with intervention group
(versus Control). To account for potential nonlinearity of the time
effect, time was modeled as a categorical variable. Thus, the
omnibus intervention group x time interaction was calculated on
6d f[ ( 4 21=3) groups* (321=2) time points]. Additionally, we
used mixed models to regress time-varying insulin sensitivity (SI)
on time plus each time-varying FPPD component. The
coefficients for each time-varying FPPD component in these
models indicated whether (averaged across all time points) the
FPPD components were positively or negatively related to SI.T h e
Figure 1. Flow of Participants through the CALERIE trial at Pennington Biomedical Research Center. This Figure has been published
previously [10,25].
doi:10.1371/journal.pone.0028190.g001
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2 statistic was used to determine the between person
variance in SI [19].
Results
Information on the main determinants from CALERIE is
reported elsewhere. Briefly, CR and CR+EX improved two
biomarkers associated with longevity, reduced core body temper-
ature and fasting insulin concentrations as well as 24-hour energy
expenditure, DNA damage, and cardiovascular risk profiles
[10,22]. Also, CR and CR+EX improved weight and fat mass,
pancreatic beta cell function, and intrahepatic lipid content
[12,23].
Fasting to Postprandial Changes in Metabolites
Using PCA to analyze changes in the fasting-to-postprandial
difference (FPPD), we identified single components for FPPD for
each of the major analyte modules– FFA, AC, and AA– with
eigenvalues of 6.37, 8.67, and 7.88 respectively, explaining 80%,
20% and 53% of the variance in the component (Table 1). At the
initial assessment, individual FFA and AC metabolites generally
decreased from fasting to the postprandial state, particularly those
that loaded heavily as part of the FFA and AC components
(Table 2). In contrast, individual AA concentrations increased in
the transition to the postprandial state (Table 2).
In response to CR, the AC FPPD was amplified (more negative
FPPD) over time relative to Control (P=0.02 at 3 mo., P=0.002
at 6 mo., overall P,0.001) (Figure 2B). A similar trend was
observed for the CR+EX group (P=0.09 at 3 mo., P=0.08 at 6
mo.; Figure 2B). In response to CR, the FFA FPPD was also
amplified (p=0.08 at 3 mo., p=0.40 at 6 mo., overall p=0.07,
Figure 2A). In response to both CR and CR+EX, the change in
AA FPPD was not significant (overall p=0.87). In response to
LCD, there were no sustained responses in AC, FFA, or AA FPPD
(P.0.10 for all). However, the increase in FPPD for AC and FFA
in subjects exposed to CR supports the conclusion that these
subjects achieved an increase in metabolic flexibility as a
consequence of the intervention.
Relations among SI, exercise, and metabolite
concentrations
As previously reported [12], between baseline and six months,
there was significant improvement in SI in the CR+EX group
and a trend towards improvement in SI in the CR group
compared to Control (P=0.01, P=0.08, respectively). For each
of these treatment groups, we observed a broad range of changes
in insulin sensitivity; specifically, despite an average improve-
ment in insulin sensitivity for each group, the individual
participant responses were varied (Figure 3A). To better
understand how insulin sensitivity improvements related to
changes in FPPD, irrespective of how the change in SI was
achieved, all subjects were included in these regression analyses
ignoring group assignment (Figure 3B). There were no significant
relations between FPPD in FFA and time-varying SI at 3 months
(P=0.54) or at six months (P=0.91). In contrast, in a model that
predicted SI, given both time-varying AC and AA components,
FPPD in AC concentrations were inversely related to time-
varying SI (P=0.04; Figure 4A), and FPPD in AA concentrations
were positively related to time-varying SI (P=0.04; Figure 4B).
The AA and AC FPPD scores explained 18% of the between
person variance in SI. These results indicate that averaged across
all time points, higher SI was associated with better metabolic
flexibility as represented by larger changes in AC and AA FPPD
scores.
In order to determine whether larger FPPD corresponded to
changes in fasting concentrations, postprandial concentrations or
both, we evaluated raw data for individual metabolites loading
most heavily on each component. By evaluating raw data, the
Table 1. Principal Components Analyses (PCA) for Fasting to
Postprandial Changes in Metabolites.*
Constituents Loadings Eigen-value Cumulative Variance
Post-Pre Fatty Acid Component 1
Palmitic acid 0.96 6.37 0.80
Linoleic acid 0.95
Oleic acid 0.95
Myristic acid 0.93
Palmitoleic acid 0.91
Stearic acid 0.87
alpha-Linolenic acid 0.86
Arachidonic acid 0.66
Post-Pre Acylcarnitine Component 1
C12:1 0.77 8.67 0.20
C16 0.77
C14:1 0.75
C14:2 0.72
C16:2 0.67
C16:1 0.67
C12 0.69
C18:1 0.66
C6-DC 0.62
C10:1 0.61
C10 0.56
C8:1 0.54
C8 0.53
C10-OH/C8-DC 0.53
C18:2 0.53
C8:1-DC 0.51
Post-Pre Amino Acid Component 1
Leucine/Isoleucine 0.91 7.88 0.53
Phenylalanine 0.91
Methionine 0.87
Histidine 0.83
Valine 0.81
Tyrosine 0.81
Aspartate/Asparagine 0.81
Serine 0.79
Proline 0.71
Ornithine 0.66
Arginine 0.65
Glycine 0.56
Alanine 0.56
*Changes were computed as postprandial metabolite concentration minus
preprandial metabolite concentration. For these differences, PCA was
performed separately for each metabolite class: fatty acids, acylcarnitines, and
amino acids. Key metabolites within each component (i.e., metabolites with
component load $|0.5|) are presented.
doi:10.1371/journal.pone.0028190.t001
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Metabolite Changes Preprandial Median (IQR) Postprandial Median (IQR)
Free Fatty Acids
Myristic acid, FA-C14:0 (mM) 6.64 (4.21) 2.00 (1.82)
Palmitoleic acid FA-C16:1(v-7) (mM) 13.19 (11.31) 1.41 (1.01)
Palmitic acid, FA-C16:0 (mM) 110.5 (60.1) 22.9 (16.7)
a-Linolenic acid, FA-C18:3(v-3) (mM) 5.15 (2.40) 1.25 (1.11)
Linoleic acid, FA- C18:2(v-6) (mM) 77.4 (53.1) 16.5 (10.9)
Oleic acid, FA-C18:1(v-9) (mM) 165.7 (64.4) 31.9 (26.0)
Stearic acid, FA-C18:0 (mM) 42.0 (18.0) 11.0 (7.4)
Arachidonic acid, FA-C20:4(v-6) (mM) 4.18 (1.62) 2.41 (1.60)
Acylcarnitines
Acetyl carnitine, C2 (nM) 6941.3 (3053.4) 4169.4 (1929.1)
Propionyl carnitine, C3 (nM) 386.6 (243.2) 471.9 (273.9)
Butyryl/Isobutyryl carnitine, C4/Ci4 (nM) 136.0 (112.8) 160.3 (64.5)
Tiglyl carnitine, C5:1 (nM) 52.0 (21.6) 48.1 (25.1)
Isovaleryl/3-Methylbutyryl/2-Methylbutyryl carnitine, C5’s (nM) 102.0 (54.8) 110.6 (61.0)
b-Hydroxy butyryl carnitine, C4OH (nM) 21.0 (18.0) 16.9 (19.6)
Hexanoyl carnitine, C6 (nM) 0 (0) 21.3 (69.2)
3-Hydroxy-isovaleryl/Malonyl carnitine, C5OH/C3DC (nM) 92.8 (88.0) 104.1 (111.2)
Methylmalonyl/Succinyl carnitine, Ci4DC/C4DC (nM) 21.8 (14.1) 22.6 (13.7)
Octenoyl carnitine, C8:1 (nM) 151.4 (76.3) 122.8 (68.4)
Octanoyl carnitine, C8 (nM) 70.1 (32.5) 29.3 (19.1)
Glutaryl carnitine, C5DC (nM) 28.9 (17.7) 23.0 (13.7)
Adipoyl carnitine, C6DC (nM) 39.4 (29.0) 27.6 (18.9)
Decatrienoyl carnitine, C10:3 (nM) 96.8 (47.7) 71.0 (41.0)
Decadienoyl carnitine, C10:2 (nM) 28.5 (11.7) 21.1 (15.2)
Decenoyl carnitine, C10:1 (nM) 140.5 (67.3) 58.8 (29.5)
Decanoyl carnitine, C10 (nM) 142.1 (72.2) 45.4 (74.1)
3-Hydroxy-decanoyl/Suberoyl carnitine, C10-OH/C8-DC (nM) 14.1 (7.4) 6.0 (4.0)
Dodecenoyl carnitine, C12:1 (nM) 57.2 (17.3) 26.2 (12.4)
Lauroyl carnitine, C12 (nM) 38.6 (23.2) 16.2 (10.1)
3-Hydroxy-dodecanoyl/Sebacoyl carnitine, C12-OH/C10-DC (nM) 4.1 (2.5) 1.5 (2.5)
Tetradecadienoyl carnitine, C14:2 (nM) 23.1 (12.2) 6.9 (5.1)
Tetradecenoyl carnitine, C14:1 (nM) 39.4 (17.7) 12.4 (6.0)
Myristoyl carnitine, C14 (nM) 12.7 (7.4) 8.5 (4.4)
3-Hydroxy-tetradecenoyl carnitine, C14:1-OH (nM) 8.7 (5.3) 6.0 (5.1)
3-Hydroxy-tetradecanoyl/Dodecanedioyl carnitine, C14-OH/C12-DC (nM) 5.6 (3.9) 3.5 (3.2)
Palmitoyl carnitine, C16 (nM) 60.8 (20.4) 42.4 (15.6)
3-Hydroxy-hexadecanoyl/Tetradecanedioyl carnitine, C16-OH/C14-DC (nM) 2.1 (1.9) 2.1 (1.6)
Linoleyl carnitine, C18:2 (nM) 54.1 (18.3) 38.1 (21.8)
Oleyl carnitine, C18:1 (nM) 96.7 (40.3) 61.7 (22.1)
Stearoyl carnitine, C18 (nM) 26.2 (9.0) 23.7 (11.4)
3-Hydroxy-octadecenoyl carnitine, C18:1-OH (nM) 3.9 (1.9) 2.3 (1.8)
3-Hydroxy-octadecanoyl/Hexadecanedioyl carnitine, C18-OH/C16-DC (nM) 3.2 (2.8) 3.0 (1.8)
Arachidoyl carnitine, C20 (nM) 3.5 (2.6) 3.2 (2.5)
Octadecenedioyl carnitine, C18:1-DC (nM) 4.3 (2.3) 4.0 (2.4)
3-Hydroxy-eicosanoyl/Octadecanedioyl carnitine, C20-OH/C18-DC (nM) 4.7 (3.5) 4.1 (3.7)
Docosanoyl carnitine, C22 (nM) 2.2 (1.8) 1.9 (1.6)
3-Hydroxy-cis-5-octenoyl/Hexenedioyl carnitine, C8:1-OH/C6:1-DC (nM) 22.1 (12.2) 16.0 (8.0)
Heptanedioyl carnitine, C7-DC (nM) 0 (6.2) 0 (4.9)
Octenedioyl carnitine, C8:1-DC (nM) 13.5 (8.4) 12.1 (7.3)
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changes in the fasting concentrations, as opposed to the
postprandial concentration of the metabolites; that is, increased
fasting AC and decreased fasting AA over time. As seen in
Figure 5, in response to caloric restriction (CR), fasting AC
concentrations increased while postprandial changes were vari-
able. For AAs, despite a reduction in the AA difference in response
to CR, larger pre-postprandial differences in AAs were related to
higher SIs. These observations emphasize that there were not one
to one correlations between CR and improvements in SI.
However, it remained unclear for those with the largest time
varying SI whether the pre to postprandial AA differences
increased over time because the fasting AA concentrations
decreased or the post-prandial concentrations increased. To
address this, we evaluated the mean pre and postprandial AAs
for participants with the six largest and six smallest predicted SI
changes. As seen in Figure 6, for those with high SI changes fasting
AA concentrations decreased while for those with low SI changes,
fasting AA concentrations increased or remained unchanged.
Postprandial AA concentrations decreased over time both in those
with the most and least SI improvements. Therefore, for both ACs
and AAs, the larger FPPDs arose primarily from changes in fasting
concentrations with increases in ACs and decreases in AAs.
Discussion
In this randomized controlled trial of three healthy lifestyle
interventions (CR, CR+EX, and a healthy weight maintenance diet)
and a very low calorie diet, we observed that the CR intervention
significantly increased the fasting-to-postprandial difference (FPPD)
in circulating acylcarnitines (AC) and free fatty acids (FFA).
Moreover, we observed that increased FPPD for both AC and AA
were related to greater insulin sensitivity. Thus, this study expands
prior investigations of metabolic flexibility from 1) acute responses to
an infusion or meal to responses to a prolonged intervention, 2)
responses to glucose/insulin infusions to more clinically-relevant
mixedmeals,3)assessmentsmadebyincreasesinRQtochangesina
broad panel of metabolic intermediates that includes both substrates
and products of key energy producing pathways.
The term metabolic flexibility is used to describe the efficient
transition between substrate utilization in response to changes in
substrate supply or energy demand. One example is the shift from
the use of fatty acids as the main energy source during fasting
conditions towards glucose utilization in a fed state [3]. Three
months of CR led to an increased gradient in pre- to postprandial
AC concentrations, primarily due to an increase in fasting AC
concentrations. Since AC are intermediates in fatty acid oxidation,
increased fasting AC concentrations reflect either a block in
complete fatty acid oxidation or increases in lipolysis and fatty acid
oxidation. These findings were supported by the concurrent
increase in the gradient of pre-postprandial FFA, primarily
mediated by increased fasting FFA concentrations. Since these
changes occurred in the setting of caloric restriction where energy
demand exceeds supply, in the fasting state when fatty acid
oxidation predominates, and these changes associate with
improved health outcomes, including insulin sensitivity, we believe
an increase in fatty acid oxidation is more likely. Thus, these data
imply that fatty acids are more effectively mobilized and oxidized
in the fasted state in subjects that have undergone CR. The
mechanisms underlying these effects remain to be investigated.
Metabolite Changes Preprandial Median (IQR) Postprandial Median (IQR)
Hexadecadienoyl carnitine, C16:2 (nM) 5.6 (3.2) 2.3 (2.4)
Palmitoleoyl carnitine, C16:1 (nM) 15.4 (6.1) 5.9 (4.6)
3-Hydroxy-palmitoleoyl/cis-5-Tetradecenedioyl carnitine, C16:1-OH/C14:1-DC, (nM) 5.3 (1.9) 3.2 (2.2)
3-Hydroxy-linoleyl carnitine, C18:2-OH (nM) 3.7 (4.3) 2.9 (4.9)
Arachidonoyl carnitine, C20:4 (nM) 6.2 (4.2) 5.7 (4.6)
Amino Acids
Glycine (mM) 359.4 (113.2) 382.6 (124.9)
Alanine (mM) 411.4 (117.8) 539.6 (126.2)
Serine (mM) 140.4 (32.5) 151.6 (32.8)
Proline (mM) 196.2 (64.1) 297.9 (55.8)
Valine (mM) 254.3 (53.8) 274.9 (58.2)
Leucine/Isoleucine (mM) 174.3 (46.5) 209.3 (63.4)
Methionine (mM) 28.7 (5.2) 34.0 (5.7)
Histidine (mM) 109.2 (38.6) 118.7 (36.9)
Phenylalanine (mM) 81.2 (13.9) 101.0 (11.0)
Tyrosine (mM) 68.4 (19.3) 81.3 (15.8)
Aspartate/Asparagine (mM) 34.3 (9.4) 36.4 (9.5)
Glutamate/Glutamine (mM) 102.9 (36.9) 105.6 (40.5)
Ornithine (mM) 69.9 (25.0) 90.4 (29.6)
Citrulline (mM) 30.7 (11.8) 28.4 (10.7)
Arginine (mM) 134.1 (36.4) 152.1 (45.5)
*Those loading most heavily (component load $|0.5|) in principal component analyses are identified in bold.
doi:10.1371/journal.pone.0028190.t002
Table 2. Cont.
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PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e28190To our knowledge, this is the first report of a relation between
an increased FPPD for AA and greater insulin sensitivity. While in
prior investigations, amplified FPPD gradients in fatty acid and
glucose oxidation have been recognized as signs of improved
metabolic flexibility [4,8], there has been little focus on AA
metabolism in this context. Our findings here are consistent with
our prior studies showing that elevated fasting concentrations of
branched chain amino acids (BCAA) and related metabolites are
associated with insulin resistance [11,16]. Interestingly, in the
current investigation, BCAA garnered the highest loadings on the
AA principal component. Here, we observed that the ability to
modulate AA concentrations was associated with improved insulin
sensitivity, and this modulation was due primarily to a reduction in
fasting AA concentrations. Further, since dietary composition was
controlled and maintained constant throughout the investigation,
changes in AA concentrations are not likely related to dietary
changes. These observations emphasize that the concept of
metabolic flexibility should not be limited to discussions of fat
and glucose metabolism but should also include AA metabolism.
Here, we showed that CR (at a level of 225% from basal
energy requirements) improved the ability to shift energy
substrates with feeding, and that caloric restriction plus exercise
(CR+EX), with an identical relative energy deficit, imparted
roughly half of the ability to shift substrate seen with CR alone. In
contrast, in a study by Kelley and Goodpaster, a combination of
weight loss and exercise training increased the rate of fatty acid
relative to glucose oxidization in the fasting state (lower fasting
Figure 2. Trajectories of Fasting to Postprandial Metabolic
Intermediate Concentration Changes over Time by Interven-
tion Group. Fasting to postprandial difference (FPPD) scores were
computedas postprandial minus fasting concentration. Difference scores
were used in principal component analyses and single component
solutions were retained as described in Results. FPPD component scores
in Figures A-C were calculated as: (1) FPPD=S1*(I1)+S2*(I2) +… Sk*(Ik);
where: I1-ik are the k individual items used in the principal components
analysis; S1–Sk are standardized scoring coefficients from the principal
component analysis; and, I1-Ik are entered as (I/SdI) for each item. With
equation 1, the FPPD component score is the average of the mean post-
preprandial differences across items with each item weighted by its
standardized scoring coefficient. Mean difference are expressed in
standard deviation units. Significant trends (P,0.10) are identified with
an asterisk (*) and significant group by time interactions are indicated
with a ({). CR=Caloric restriction. CR+EX=Combined caloric restriction
and exercise. LCD=Liquid calorie diet. A. Free Fatty Acids (FFA). (CR * 3
months P=0.07) B. Acylcarnitines (AC). (CR * 3 months P=0.02; CR * 6
month P=0.002; CR+EX * 3 month P=0.09; CR+EX * 6 month P=0.08) C.
Amino Acids (AA).
doi:10.1371/journal.pone.0028190.g002
Figure 3. Baseline to Month Three Changes in Insulin
Sensitivity: Average Group Improvements Despite Varied
Individual Responses. Each bar represents insulin sensitivity
improvements for participating individuals. A. By intervention group.
CR=Caloric restriction; CR+EX=Caloric restriction with exercise; Con-
trol=Healthy weight maintenance diet; LCD=Liquid calorie diet B.
Intervention groups combined.
doi:10.1371/journal.pone.0028190.g003
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PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e28190Figure 4. Correlation Between Fasting to Postprandial Component Changes and Predicted SI Change Over Time. As described in
Methods, fasting and postprandial concentrations of amino acids and acylcarnitines were measured at baseline, three months, and six months, and
fasting to postprandial components were generated. SI was determined from insulin and glucose concentrations measured during a frequently
sampled intravenous tolerance test at each of baseline, three, and six months. Linear models were used to relate time varying concentrations of
fasting to postprandial amino acid and acylcarnitine component to time varying insulin sensitivity (SI). Scatter plots depict the relation between
fasting to postprandial component scores and predicted SI. A. Relation between Acylcarnitines (AC) Fasting to Postprandial Component Scores and
Predicted SI Over Time. Since postprandial AC concentrations are larger than fasting, more negative fasting to postprandial differences represent
more metabolic flexibility. B. Relation between Amino Acid (AA) Fasting to Postprandial Component Scores and Predicted SI Over Time.
doi:10.1371/journal.pone.0028190.g004
Figure 5. Preprandial and postprandial concentrations of acylcarnitines in response to caloric restriction (CR). Baseline and three
month acylcarnitine concentrations are shown for both fasting (preprandial) and postprandial assessments. The six acylcarnitines that had the largest
loadings on the acylcarnitine factor (see Table 1) are shown.
doi:10.1371/journal.pone.0028190.g005
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PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e28190respiratory quotient [RQ]) as compared to before the interven-
tion [8]; however, in the absence of exercise training, there was
little change in fasting RQ with CR alone [4]. We note that our
study differs from that of Kelley and Goodpaster in terms of the
‘‘feeding’’ challenge (clamp versus a mixed meal), assessment of
substrate oxidation with metabolic intermediates rather than RQ,
targeting the transition from the fasted to the fed state in contrast
to their emphasis on fasting fat oxidation alone, and differences in
exercise regimens or timing of assessments after training cessation
[20]. Moreover, Kelley and Goodpaster observed that increased
fasting fatty acid oxidation relative to glucose oxidation was
highly associated with improvements in SI [8]. While we observed
a relationship between the two, we noted that Si improvements
were greatest in the CR+EX group, but substrate utilization
improvements were greatest in the CR group. We also note that
the subjects in the CALERIE study were healthy with normal
insulin sensitivity prior to the CR or CR + EX interventions,
whereas those studied by Goodpaster and Kelly were insulin
resistant [4,8,21]. These findings suggest that while improve-
ments in insulin sensitivity are related to metabolic flexibility
changes, there are additional components of the variability of
each that are yet to be identified.
Our observations add metabolic flexibility, as measured by
changes in metabolic intermediates in response to a mixed meal, to
the list of improvements that occur in the setting of CR elucidated
through the CALERIE study. In addition to this effect, CR or
CR+EX reduced core body temperature, 24-hour energy
expenditure, fasting insulin concentrations, DNA damage, and
cardiovascular risk profiles [10,22]. Matched for energy deficit,
CR and CR+EX produced similar improvements in reductions in
weight and fat mass, pancreatic beta cell function, and
intrahepatic lipid content [12,23]. In contrast, while both CR
and CR+EX increased adiponectin concentrations, and skeletal
muscle sirtuin 1 (SIRT1) expression, these increases were more
pronounced in the CR alone group, suggesting that these effects
were primarily mediated by the CR component of the combined
intervention [24]. Similarly, 25% CR produced a greater
metabolic adaptation (as defined by a reduction in energy
expenditure) than would be predicted for loss in body mass alone,
and that was not observed with 12.5% CR+EX [25].
Figure 6. Preprandial and postprandial concentrations of amino acids for those with the highest and lowest insulin sensitivity
changes. Baseline and three month amino acids concentrations are shown for both fasting (preprandial) and postprandial assessments. The five
amino acids that had the largest loadings on the amino acid factor (see Table 1) are shown. Leu/Ile=leucine/isoleucine, Phe=phenylalanine,
Met=Methionine, His=Histidine, Val=Valine.
doi:10.1371/journal.pone.0028190.g006
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PLoS ONE | www.plosone.org 9 April 2012 | Volume 7 | Issue 4 | e28190The careful control of the caloric restriction and exercise
interventions is a great strength of this analysis. To minimize type I
error rates, we used PCA to reduce the dimensionality of the data.
We performed these analyses cognizant that using PCA in small
samples can result in ‘overfitting,’ where findings are sample-
specific rather than representative of the population of interest
[26]. However, the PCA-derived components and loadings here
were both substantively credible and consistent with findings from
previous studies using PCA on the same or similar metabolite
measures [11,16,17,18]. With a sample size of 46, we had limited
power to observe small to medium sized effects, and given this, we
present statistical trends (0.05,P,0.10) in several instances.
Additionally, while the metabolite profiles can identify perturba-
tions in systemic trafficking of specific carbon fuels, they do not
provide definitive information about metabolic flux. Nonetheless,
the results of such analyses provide a valuable guide for further
investigations seeking to identify underlying mechanisms.
In summary, CR improved metabolic flexibility evidenced by
higher fasting AC and FFA concentrations and widened FPPD
gradients for these metabolites. Furthermore, the change in the
FPPD gradient of AC and AA concentration was related to
improvements in insulin sensitivity.
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